DE68928535D1 - Isolierung von fetalen zellen aus mütterlichem blut zur ausführung von pränataler diagnostik - Google Patents

Isolierung von fetalen zellen aus mütterlichem blut zur ausführung von pränataler diagnostik

Info

Publication number
DE68928535D1
DE68928535D1 DE68928535T DE68928535T DE68928535D1 DE 68928535 D1 DE68928535 D1 DE 68928535D1 DE 68928535 T DE68928535 T DE 68928535T DE 68928535 T DE68928535 T DE 68928535T DE 68928535 D1 DE68928535 D1 DE 68928535D1
Authority
DE
Germany
Prior art keywords
pct
cells
isolation
maternal blood
carrying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68928535T
Other languages
English (en)
Other versions
DE68928535T2 (de
Inventor
Utz Mueller
Catherine Hawes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flinders Technologies Pty Ltd
Original Assignee
Flinders Technologies Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flinders Technologies Pty Ltd filed Critical Flinders Technologies Pty Ltd
Application granted granted Critical
Publication of DE68928535D1 publication Critical patent/DE68928535D1/de
Publication of DE68928535T2 publication Critical patent/DE68928535T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE68928535T 1988-12-06 1989-11-29 Isolierung von fetalen zellen aus mütterlichem blut zur ausführung von pränataler diagnostik Expired - Fee Related DE68928535T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ182488 1988-12-06
PCT/AU1989/000517 WO1990006509A1 (en) 1988-12-06 1989-11-29 Isolation of fetal cells from maternal blood to enable prenatal diagnosis

Publications (2)

Publication Number Publication Date
DE68928535D1 true DE68928535D1 (de) 1998-02-12
DE68928535T2 DE68928535T2 (de) 1998-04-16

Family

ID=3773565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68928535T Expired - Fee Related DE68928535T2 (de) 1988-12-06 1989-11-29 Isolierung von fetalen zellen aus mütterlichem blut zur ausführung von pränataler diagnostik

Country Status (11)

Country Link
US (1) US5503981A (de)
EP (1) EP0447424B1 (de)
JP (1) JP2935741B2 (de)
CN (1) CN1021257C (de)
AT (1) ATE161960T1 (de)
CA (1) CA2004592A1 (de)
DE (1) DE68928535T2 (de)
DK (1) DK107391A (de)
ES (1) ES2112833T3 (de)
NZ (1) NZ231621A (de)
WO (1) WO1990006509A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344315B1 (en) 1986-01-16 2002-02-05 The Regents Of The University Of California Chromosome-specific staining to detect genetic rearrangements associated with chromosome 3 and/or chromosome 17
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US5756696A (en) 1986-01-16 1998-05-26 Regents Of The University Of California Compositions for chromosome-specific staining
US6872817B1 (en) 1986-01-16 2005-03-29 The Regents Of The Univ. Of California Method of staining target interphase chromosomal DNA
US7115709B1 (en) * 1986-01-16 2006-10-03 The Regents Of The University Of California Methods of staining target chromosomal DNA employing high complexity nucleic acid probes
US6475720B1 (en) 1986-01-16 2002-11-05 The Regents Of The University Of California Chromosome-specific staining to detect genetic rearrangements associated with chromosome 3 and/or chromosome 17
DK0412700T3 (da) * 1989-08-03 1998-04-06 Univ California Fremgangsmåde til isolering af føtale cytrophoblastceller
US5641628A (en) * 1989-11-13 1997-06-24 Children's Medical Center Corporation Non-invasive method for isolation and detection of fetal DNA
ATE162631T1 (de) * 1989-11-13 1998-02-15 Childrens Medical Center Ein nichtinvasives verfahren zur trennung und zum nachweis von fetaler dna
US5153117A (en) * 1990-03-27 1992-10-06 Genetype A.G. Fetal cell recovery method
FR2682481A1 (fr) * 1991-10-11 1993-04-16 Saint Cy Scp Procede d'obtention de cellules trophoblastiques d'un fóoetus.
EP0610359A1 (de) * 1991-10-23 1994-08-17 Cellpro Incorporated Verfahren zur einrichtung fetaler stammzellen von mütterlichem blut
FR2685777A1 (fr) * 1991-12-31 1993-07-02 Bertin & Cie Procede de depistage prenatal d'anomalies fóoetales et procede de depistage prenatal du sexe.
DE4222573C1 (de) * 1992-05-16 1993-08-12 Dorothee Dr. 4400 Muenster De Ahlert
US5457024A (en) * 1993-01-22 1995-10-10 Aprogenex, Inc. Isolation of fetal erythrocytes
US5662813A (en) * 1994-10-21 1997-09-02 Bioseparations, Inc. Method for separation of nucleated fetal erythrocytes from maternal blood samples
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5801145A (en) * 1996-02-09 1998-09-01 Ontario Cancer Institute Method for selectively purging CD77+ cells from bone marrow
AUPO931997A0 (en) * 1997-09-22 1997-10-09 Flinders Technologies Pty Ltd Enrichment and identification of trophoblast cells in maternal peripheral blood
US6221596B1 (en) 1999-05-17 2001-04-24 Motobit Ltd. System and method for identifying and isolating rare cells from a mixed population of cells
AU5967100A (en) * 1999-07-21 2001-02-13 Britta Christensen A novel method for the improved isolation of a target cell population
DE19964044C2 (de) * 1999-12-30 2001-11-22 Frank Hans Georg Verfahren zur Identifizierung von Substanzen, die Säugetier-Epitope nachahmen
PL361223A1 (en) * 1999-12-30 2004-09-20 Aplagen Gmbh Method for identifying substances which mimic mammal epitopes
US20020045196A1 (en) * 2000-05-12 2002-04-18 Walt Mahoney Methods of isolating trophoblast cells from maternal blood
US20050100951A1 (en) * 2000-10-26 2005-05-12 Biocept, Inc. 3D format biochips and method of use
FR2824144B1 (fr) 2001-04-30 2004-09-17 Metagenex S A R L Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
CA2492631C (en) * 2002-05-31 2013-03-12 Genetic Technologies Limited Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
US8895298B2 (en) 2002-09-27 2014-11-25 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
WO2004078999A1 (en) * 2003-03-05 2004-09-16 Genetic Technologies Limited Identification of fetal dna and fetal cell markers in maternal plasma or serum
US20050181429A1 (en) * 2003-04-03 2005-08-18 Monaliza Medical Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
US20040197832A1 (en) * 2003-04-03 2004-10-07 Mor Research Applications Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
JP2007508017A (ja) * 2003-10-08 2007-04-05 ザ トラスティーズ オブ ボストン ユニバーシティ 染色体異常の出生前診断のための方法
US7439062B2 (en) * 2004-12-23 2008-10-21 Biocept, Inc. Beads for capturing target cells from bodily fluid
FR2880897B1 (fr) 2005-01-18 2010-12-17 Inst Nat Sante Rech Med Methode de detection, non invasive, prenatale, in vitro de l'etat sain normal, de l'etat de porteur sain ou de l'etat de porteur malade de la mucoviscidose
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2029779A4 (de) 2006-06-14 2010-01-20 Living Microsystems Inc Verwendung hoch paralleler snp-genotypisierung zur fötalen diagnose
EP2589668A1 (de) 2006-06-14 2013-05-08 Verinata Health, Inc Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP3032259B1 (de) * 2007-05-01 2020-04-15 Tel Hashomer Medical Research Infrastructure and Services Ltd. Verfahren zum nachweis von trophoblasten in mütterlichem blut basierend auf cytokeratin-7
CA2752838A1 (en) * 2008-02-18 2009-08-27 Genetic Technologies Limited Cell processing and/or enrichment methods
PT2562268T (pt) 2008-09-20 2017-03-29 Univ Leland Stanford Junior Diagnóstico não invasivo de aneuploidia fetal por sequenciação
SG175282A1 (en) 2009-04-21 2011-11-28 Genetic Technologies Ltd Methods for obtaining fetal genetic material
CA2765779A1 (en) * 2009-06-24 2010-12-29 Fund For Medical Research Development Of Infrastructure And Health Servi Ces - At Rambam Medical Center Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
CN101935700A (zh) * 2010-07-15 2011-01-05 浙江大学 鉴定绵羊早期胚胎性别的牙釉蛋白基因引物及其应用
US10058306B2 (en) 2012-06-22 2018-08-28 Preprogen, LLC Method for obtaining fetal cells and fetal cellular components
CN103230416A (zh) * 2013-04-16 2013-08-07 中国人民解放军第三军医大学第三附属医院 一种小鼠合体滋养细胞微绒毛膜的制备方法及其应用
AU2015329709B2 (en) * 2014-10-10 2020-09-10 Wayne State University Methods and compositions relating to assays of fetal extravillous trophoblast cells
RU2695356C1 (ru) * 2018-11-14 2019-07-23 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ прогнозирования состояния плода при преждевременном разрыве плодных оболочек с 24 до 33 недель беременности
CN112980779B (zh) * 2021-05-20 2021-08-24 广州凯普医药科技有限公司 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU647741B2 (en) * 1989-12-01 1994-03-31 Regents Of The University Of California, The Methods and compositions for chromosome-specific staining

Also Published As

Publication number Publication date
US5503981A (en) 1996-04-02
ATE161960T1 (de) 1998-01-15
CA2004592A1 (en) 1990-06-06
JPH04502060A (ja) 1992-04-09
CN1043788A (zh) 1990-07-11
EP0447424B1 (de) 1998-01-07
JP2935741B2 (ja) 1999-08-16
NZ231621A (en) 1992-11-25
WO1990006509A1 (en) 1990-06-14
DE68928535T2 (de) 1998-04-16
DK107391D0 (da) 1991-06-06
EP0447424A1 (de) 1991-09-25
DK107391A (da) 1991-07-31
EP0447424A4 (en) 1992-06-24
CN1021257C (zh) 1993-06-16
ES2112833T3 (es) 1998-04-16

Similar Documents

Publication Publication Date Title
DE68928535T2 (de) Isolierung von fetalen zellen aus mütterlichem blut zur ausführung von pränataler diagnostik
ATE194166T1 (de) Verfahren zur gewinnung fötaler zellen
IL129382A0 (en) Use of anti-embryonic hemoglobin antibodies to identify fetal cells
ES2061273T3 (es) Ensayo para proteinas glicadas de la sangre.
Gamzu et al. The hemizona assay is of good prognostic value for the ability of sperm to fertilize oocytes in vitro
Mulivor et al. Origin of the alkaline phosphatases in amniotic fluid
CN101918445A (zh) 用于早期妊娠诊断的组合物和方法
Daniel Jr Uterine proteins and embryonic development
SHAPIRO et al. Protein composition of rabbit oviducal fluid
ATE163971T1 (de) Verfahren zur isolierung von fetalen zytotrophoblastzellen
Jauniaux et al. Coelomic fluid chorionic gonadotrophin and protein concentrations in normal and complicated first trimester human pregnancies
Davies An ELISA for the detection of maternal anti-trophoblast antibodies in human pregnancy
Martinez et al. Reliability of home urinary LH tests for timing of insemination: a consumer's study
Horn et al. Prenatal diagnosis of Menkes’ syndrome by direct copper analysis of trophoblastic tissue
Gimsing et al. Vitamin B12 binding proteins in amniotic fluid
Abdelhanine et al. Using commercial enzyme immunoassay for measuring pregnancy-associated glycoproteins to diagnose pregnancy in dairy cows under field conditions in Algeria
Shahani et al. Early pregnancy factor (EPF) as a marker for the diagnosis of subclinical embryonic loss
AHMED et al. Determination of the stage of gestation by the assay of chorionic gonadotrophin and Schwangerschaftsprotein 1
AYAD et al. RUDN JOURNAL OF AGRONOMY AND ANIMAL INDUSTRIES
Koskull et al. Localization of insulin-like growth factor-binding protein and endometrial beta-lactoglobulin in cultured decidual and chorionic villus cells
Youssef et al. Failure to document fetal cells in maternal circulation using the Selypes-Lorencz “air-culture” cytogenetic technique
Chapman et al. Implantation: biological and clinical aspects
SU656605A1 (ru) Способ прогнозировани молочной продуктивности крупного рогатого скота
Trnka et al. " Map" of proteins resolved from human chorionic villi by two-dimensional electrophoresis.
Brambati Fetal Diagnosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee